MEDICAL WRITING CONSULTING SERVICES

NIH RePORTER · NIH · N02 · $27,295 · view on reporter.nih.gov ↗

Abstract

The NIH is seeking senior-level, industry-experienced drug discovery and development consultants with expertise in the following specific disciplines to provide leadership and technical guidance on drug discovery and development projects in the ultra-rare gene-based therapy (URGENT) program. The area of expertise needed in medical writing.

Key facts

NIH application ID
11199800
Project number
75N95023P00692-P00001-0-2
Recipient
CCS ASSOCIATES, INC.
Principal Investigator
Caroline C Sigman
Activity code
N02
Funding institute
NIH
Fiscal year
2024
Award amount
$27,295
Award type
Project period
2023-09-14 → 2025-09-13